AstraZeneca Pharma India Ltd Q1 Results
- BSE: 506820
- NSE: ASTRAZEN
- ISIN: INE203A01020
- Sector: Biotechnology & Drugs
BSE
8,508.80
-16.30 (-0.19%)
-16.30 (-0.19%)Volume265.00
Updated: Fri 17 Apr, 2026 | 15:45:41
NSE
8,498-30.00 (-0.35%)
-30.00 (-0.35%)Volume4.99 K
Updated: Fri 17 Apr, 2026 | 15:30:02
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - AstraZeneca Pharma India Ltd Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 462.13 | 417.48 | 10.70% |
| Depreciation/ Amortization | 16.57 | 17.69 | -6.33% |
| Operating Income | 64.18 | 63.00 | 1.87% |
| Net Income | 55.83 | 58.25 | -4.15% |
| Other Operating Expenses Total | 61.11 | 47.35 | 29.06% |
| Net Income Before Taxes | 74.70 | 78.47 | -4.80% |
| Total Revenue | 526.31 | 480.48 | 9.54% |
| Selling/ General/ Admin Expenses Total | 88.68 | 87.15 | 1.76% |
| Diluted Normalized EPS | 22.44 | 25.01 | -10.27% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.